Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the impact of semaglutide on kidney and cardiovascular risks in individuals with type 2 diabetes and chronic kidney disease, finding significant reductions in key health outcomes.
This study evaluated the effects of a multi-species synbiotic preparation on metabolic profiles in elderly patients with type 2 diabetes and high cardiovascular risk, finding significant reductions in weight, cholesterol, and glucose levels.
A pharmacist-driven text messaging intervention was studied to improve diabetes self-management in uninsured patients, resulting in a significant reduction in HbA1c levels.
This study evaluated ultra-rapid insulin lispro (URIL) compared to standard insulin lispro (IL) in closed-loop systems for type 1 diabetes, finding URIL improved glucose control metrics.
This study evaluated the impact of the Vitadio digital health application on glycemic control in patients with Type 2 Diabetes Mellitus, finding significant improvements in several health metrics.
This study investigated the effects of Vitamin C supplementation on oxidative stress markers in patients with type 2 diabetes, finding significant reductions in malondialdehyde and advanced glycation end products.
The study evaluated the impact of automated insulin delivery on glycaemia and sleep in young people with type 1 diabetes, finding significant improvements in HbA1c but negative effects on sleep.
This study evaluated the impact of Cognitive Behavioral Therapy for Insomnia (CBTI) on sleep regularity and anxiety in individuals with Type 2 Diabetes. CBTI showed significant improvements in sleep regularity and anxiety symptoms compared to Health Education (HE).
This study evaluated culturally tailored diabetes self-management education and support with real-time continuous glucose monitoring in Latino adults with uncontrolled type 2 diabetes, finding potential benefits in HbA1c reduction.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
